Legal Status Overview
Gray AreaDelaware has no peptide-specific, research-chemical-specific, or RUO-specific statute or Board of Pharmacy rule; peptide legality in Delaware is instead governed entirely by the general federal drug-approval and compounding framework. Under that framework, FDA-approved peptide drugs are prescription-only and dispensed through licensed pharmacies, while unapproved peptides sold as 'research chemicals' cannot lawfully be marketed or sold for human use even though simple possession is not itself a scheduled-substance crime. Delaware-licensed 503A compounding pharmacies remain subject to the same federal bulk-substance and compounding rules that apply nationally, including FDA's evolving 'Category 2' list for peptides used in compounding.
Key Points
- No Delaware statute, administrative code section, or Board of Pharmacy rule was found that names 'peptides,' 'research chemicals,' or research-use-only compounds as a distinct legal category, based on targeted searches for Delaware-specific peptide law. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- FDA-approved peptide drugs such as semaglutide and tirzepatide are lawfully available in Delaware only by prescription through licensed pharmacies, since they fall under the standard federal prescription-drug framework applicable in every state. [4]
- Unapproved research peptides like BPC-157 have not been approved by the FDA for any human use, and cannot legally be prescribed or sold over the counter for that purpose anywhere in the United States, including Delaware. [3]
- Delaware compounding pharmacies that prepare patient-specific peptide prescriptions operate as 503A facilities, which are required by state boards of pharmacy to comply with USP compounding standards on top of the federal 503A exemptions from FDA drug-approval and labeling requirements. [2]
- Federal law makes knowing distribution or possession with intent to distribute human growth hormone (HGH) for any use other than an FDA-authorized disease treatment a felony under 21 U.S.C. 333(e), a rule that applies in Delaware as in every other state. [1]
- A Delaware resident can lawfully obtain peptides such as semaglutide, tirzepatide, or compounded BPC-157-type products only through a valid prescription from a licensed prescriber and dispensing by a state-licensed 503A pharmacy or FDA-registered 503B outsourcing facility, not through direct-to-consumer 'research chemical' vendors. [4]
- Personal purchase or importation of unapproved research peptides into Delaware occupies a federal gray area with no Delaware-specific import or travel rule identified; U.S. Customs and Border Protection has actively interdicted bulk overseas peptide shipments nationally, so personal shipments risk seizure even without a Delaware-specific statute. [1]
Peptide-by-peptide status in Delaware
| BPC-157 | BPC-157 is not FDA-approved for any human use and cannot lawfully be marketed, prescribed, or sold for human consumption in Delaware, though it is commonly sold nationwide as an unapproved 'research chemical.' [3] |
|---|---|
| Semaglutide / Tirzepatide (GLP-1 class) | FDA-approved semaglutide and tirzepatide products are legal prescription medications in Delaware, available only through a licensed prescriber and pharmacy, while non-FDA-approved compounded or research-labeled versions of these peptides fall outside that approved pathway. [4] |
| TB-500 | TB-500 has no FDA approval for human use, placing it in the same unapproved 'research chemical' category as BPC-157 in Delaware and the rest of the United States, with no Delaware-specific rule altering that status. [4] |
| Human Growth Hormone (HGH/somatropin) | HGH is a prescription-only drug in Delaware for FDA-approved disease indications, and federal law separately makes it a felony to knowingly distribute or possess HGH with intent to distribute it for any non-approved use, such as anti-aging or bodybuilding. [1] |
Sources
Last researched: 2026-09-09
Frequently asked questions
Can I buy peptides in Delaware without a prescription?
In Delaware, FDA-approved peptide drugs cannot be lawfully purchased without a prescription, but unapproved peptides labeled 'for research use only' (like BPC-157 or TB-500) are commonly sold online without a prescription because they are marketed as not intended for human consumption, a labeling framework that carries its own legal risk if the product is actually used on humans. [4]
Can I legally import or bring research peptides into Delaware from another country?
No Delaware-specific import or travel rule for peptides was found; nationally, U.S. Customs and Border Protection has been actively seizing bulk overseas peptide shipments including semaglutide, tirzepatide, and BPC-157-related compounds, so bringing unapproved peptides into Delaware from abroad carries federal seizure risk regardless of state law. [1]
Can a Delaware telehealth provider legally prescribe peptides like semaglutide or BPC-157?
A Delaware-licensed telehealth prescriber can legally prescribe FDA-approved peptides such as semaglutide or tirzepatide within a valid patient-provider relationship, but prescribing an unapproved peptide like BPC-157 for human use falls outside the FDA-approved drug framework and is not a recognized lawful prescribing pathway. [3]
What are the penalties for selling or using unapproved peptides in Delaware?
No Delaware-specific criminal penalty for peptide possession was identified; federally, selling misbranded or unapproved peptide drugs for human use can trigger FDA misbranding, adulteration, or unapproved-new-drug enforcement, and knowingly distributing human growth hormone for non-approved uses is a distinct federal felony under 21 U.S.C. 333(e). [1]
Is compounded BPC-157 or semaglutide from a Delaware pharmacy legal?
Compounded semaglutide from a Delaware-licensed 503A pharmacy is legal when dispensed under a valid patient-specific prescription and consistent with FDA's compounding bulk-substance rules, but compounding BPC-157 is legally uncertain because BPC-157 has been treated as an unapproved substance outside FDA's list of permissible compounding bulk drugs. [2]